Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors

Journal of Medicinal Chemistry
1985.0

Abstract

In earlier distance geometry related three-dimensional quantitative structure-activity relationships (Ghose, A. K.; Crippen, G. M. J. Med. Chem. 1984, 27, 901) the interactions of the ligand atom or group with the receptor site were evaluated empirically by using mathematical optimization techniques, without considering their physicochemical properties. In the present work we show how to use various physicochemical parameters in our three-dimensional receptor mapping. We have developed a model for E. coli DHFR using the inhibition data of 25 pyrimidines and 14 triazines. It gave a correlation coefficient of 0.893 and standard deviation of 0.530. It successfully predicted the binding data of five pyrimidines and five triazines.

Knowledge Graph

Similar Paper

Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1985.0
A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1984.0
Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines
Journal of Medicinal Chemistry 1983.0
Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, x-ray crystallography, and computer graphics in structure-activity analysis
Journal of Medicinal Chemistry 1982.0
Quantitative structure-activity relationship of 5-(X-benzyl)-2,4-diaminopyrimidines inhibiting bovine liver dihydrofolate reductase
Journal of Medicinal Chemistry 1979.0
Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines
Journal of Medicinal Chemistry 1988.0
Crystallography, quantitative structure-activity relationships, (QSAR) and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazines
Journal of Medicinal Chemistry 1984.0
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines
Journal of Medicinal Chemistry 1980.0
Three-Dimensional Quantitative Structure−Activity Relationship Analysis of a Set ofPlasmodium falciparumDihydrofolate Reductase Inhibitors Using a Pharmacophore Generation Approach
Journal of Medicinal Chemistry 2004.0
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines
Journal of Medicinal Chemistry 1981.0